These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36624889)

  • 1. A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination.
    Serrano Gomez Y; Grella B; Wang H
    Case Rep Dermatol Med; 2022; 2022():4267930. PubMed ID: 36624889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of leukocytoclastic vasculitis following covid-19 vaccination: case based comprehensive review.
    Miskovic R; Radovic S; Arandjelovic S; Plavsic A; Reljic V; Peric J; Brkovic V; Stojanovic M
    Rheumatol Int; 2024 Nov; 44(11):2621-2635. PubMed ID: 39284920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytoclastic vasculitis after COVID-19 vaccination.
    Altun E; Kuzucular E
    Dermatol Ther; 2022 Mar; 35(3):e15279. PubMed ID: 34931412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination.
    Ball-Burack MR; Kosowsky JM
    J Emerg Med; 2022 Aug; 63(2):e62-e65. PubMed ID: 35690533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocytoclastic vasculitis in association with linear epidermal basement membrane zone immunoglobulin deposition: Linear vasculitis.
    Magro CM; Mo JH; Kerns MJ
    Clin Dermatol; 2022; 40(6):639-650. PubMed ID: 35907580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).
    Sandhu S; Bhatnagar A; Kumar H; Dixit PK; Paliwal G; Suhag DK; Patil C; Mitra D
    Dermatol Ther; 2021 Nov; 34(6):e15141. PubMed ID: 34546608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report.
    Buck M; Dumic I; McDermott W; Nordstrom C; Dawan S; Virata A; Martin S; Hudson A; Milovanovic T; Nordin T
    BMC Gastroenterol; 2020 Jul; 20(1):240. PubMed ID: 32727390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Complication From a Commonly Used Medication.
    Singh I; Gidda H; Nashed B
    Cureus; 2023 Mar; 15(3):e36532. PubMed ID: 37102000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous leukocytoclastic vasculitis after second dose of mRNA COVID-19 vaccine.
    Simon SC; Olsavszky V
    Dermatol Online J; 2022 Oct; 28(5):. PubMed ID: 36809133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
    Hinterseher J; Hertl M; Didona D
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination.
    Fiorillo G; Pancetti S; Cortese A; Toso F; Manara S; Costanzo A; Borroni RG
    J Autoimmun; 2022 Feb; 127():102783. PubMed ID: 34973526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Endocarditis Accompanied by Leukocytoclastic Vasculitis.
    Lunsford J; Pant P; Rush PS
    Cureus; 2024 May; 16(5):e61021. PubMed ID: 38916001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exuberant bullous vasculitis associated with SARS-CoV-2 infection.
    Gouveia PADC; Cipriano IC; de Melo MAZ; da Silva HTA; Amorim MAO; de Sá Leitão CC; Guedes MMV; Takano DM; Filgueira NA; Ferraz CE
    IDCases; 2021; 23():e01047. PubMed ID: 33457205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.
    Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B
    Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Unusual Case of Apixaban-Induced Small Vessel Vasculitis: Leukocytoclastic Vasculitis.
    Adebayo AY; Ali A; Goswami RM; Abimbolu O; Nayab K; Onyemarim H
    Cureus; 2024 Feb; 16(2):e55040. PubMed ID: 38550439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin-Induced Cutaneous Leukocytoclastic Vasculitis: A Case Report.
    Órfão A; Madeira D; Maia Duarte D; Galante Pereira F; Matos C
    Cureus; 2023 Sep; 15(9):e44616. PubMed ID: 37799214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine.
    Nida SS; Tobon GJ; Wilson M; Chauhan K
    Cureus; 2022 Sep; 14(9):e29786. PubMed ID: 36340561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.